GOLD BioAgeDiff
Biomarker1 paper1 finding
- Humans1
Associations
1Metabolic dysfunction-associated steatotic liver disease
upin humans1OR 1.11
1 study
Metabolic dysfunction-associated steatotic liver disease
upin humans1OR 1.11
GOLD BioAgeDiff raises the risk of metabolic dysfunction-associated steatotic liver disease in humans (OR = 1.11, 95% CI: 1.09-1.13).
Humansall participantsn = 10,933
Association between biological aging and premature mortality among patients with metabolic dysfunction-associated steatotic liver disease · Archives of gerontology and geriatrics · 6 Sep 2026